FIELD: chemistry.
SUBSTANCE: invention relates to organic and medical chemistry, specifically to novel 1-benzoyl-substituted-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine derivatives of general formula I, where R=H, R1=phenyl (Ia) – 1-benzoyl-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d] pyrimidine; R=H, R1=2-bromophenyl (Ib) – 1-(2-bromobenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-methylphenyl (Ic) – 1-(2-methylbenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-methoxyphenyl (Id) – 1-(2-methoxybenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3,4-dimethoxyphenyl (Ie) – 1-(3,4-dimethoxybenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-bromphhenyl (If) – 1-(3-bromobenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-methylphenyl (Ig) – 1-(3-methylbenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-methoxyphenyl (Ih) – 1-(3-methoxybenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=4-bromphhenyl (Ii) – 1-(4-bromobenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=4-methylphenyl (Ij) – 1-(4-methylbenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4 d]pyrimidine; R=H, R1=4-methoxyphenyl (Ik) – 1-(4-methoxybenzoyl)-6-(methylthio)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-furyl (Il) – 6-(methylthio)-1-(2-furoyl)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-thienyl (Im) – 6-(methylthio)-1-(2-thienylcarbonyl)-4-chloro-1H-pyrazolo[3,4-d]pyrimidine. Invention also relates to a method of producing a compound of formula (I).
EFFECT: obtaining novel heterocyclic compounds having antimicrobial activity.
2 cl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
2-ARYL-6-(METHYLTHIO)-4-CHLORO-2H-PYRAZOLO[3,4-D]PYRIMIDINES AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2708892C1 |
DERIVATIVES OF 1H-PYRAZOLO [3,4-D] PYRIMIDINE AND METHOD OF THEIR PRODUCTION | 2017 |
|
RU2638928C1 |
PYRAZOLOPYRIMIDINE DERIVATIVES AS A KINASE INHIBITOR | 2017 |
|
RU2714206C1 |
COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788148C2 |
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788147C2 |
SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
Authors
Dates
2019-12-13—Published
2019-09-26—Filed